Purpose: To compare the effect of mannitol plus hypertonic saline combination (MHS) versus hypertonic saline monotherapy (HS) on renal function in patients with traumatic brain injury (TBI). Materials and methods: This was a secondary analysis of data from the Resuscitation Outcomes Consortium Hypertonic Saline Trial Shock Study and Traumatic Brain Injury Study. The study cohort included a propensity matched subset of patients with TBI who received MHS or HS. The primary outcome measure was the maximum serum creatinine value during critical illness. Results: The cohort consisted of 163 patients in the MHS group and 163 patients in the HS group (n = 326). The maximum serum creatinine value during hospitalization was 82 ± 47 μmol/L (0.86 ± 0.26 mg/dL) in the MHS group and 76 ± 23 μmol/L (0.92 ± 0.53 mg/dL) in the HS group (difference −6 μmol/L, 95% CI −14 to 2 μmol/L, p = .151). The lowest eGFR during hospitalization was 108 ± 25 mL/min in the MHS group and 112 ± 24 mL/min in the HS group (difference −4 mL/min, 95% CI −1 to 9 mLmin, p = .150). Conclusions: The addition of mannitol to HS did not increase the risk of renal dysfunction compared to HS alone in patients with TBI.
- (MeSH): Hypertonic saline
- Acute kidney injury
- Traumatic brain injury
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine